Biological and Pharmaceutical Bulletin · 2019 · 21 citations · 37 references
Life SciencesPharmacologyPhysiologyCell SignalingRenal PathophysiologySignal TransductionEndothelial ActivationEndothelial DysfunctionEndothelial Function ModulationImpaired Kidney FunctionNitric OxideNitric Oxide-mediated VasodilationVascular Endothelial DysfunctionVascular Endothelial FunctionVascular Smooth Muscle RelaxationVascular Tone Modulation
Upon stimulation, endothelial cells release various factors to regulate the vascular tone. In particular, vasorelaxing factors, called endothelium-derived relaxing factors (EDRFs), are altered in the production and/or release, as well as their signaling every vessel and under pathophysiological states, including cardiovascular, kidney, and metabolic diseases. Although indoxyl sulfate is known as a protein-bound uremic toxin and circulating levels are elevated in the impaired kidney functions, direct impact on the vascular function, especially EDRF’s signaling, remains unclear. In this study, we hypothesize that acute exposure to indoxyl sulfate could alter vascular relaxation in the rat superior mesenteric artery. Accordingly, we measured acetylcholine (ACh)-induced endothelium-dependent relaxation in the absence and presence of several inhibitors to divide into each EDRF, including nitric oxide (NO), vasodilator prostaglandins (PGs), and endothelium-derived hyperpolarizing factor (EDHF). Indoxyl sulfate reduced the sensitivity to ACh but not sodium nitroprusside. Under cyclooxygenase (COX) inhibition or inhibitions of COX plus source of EDHF, such as small (SKCa)- and intermediate (IKCa)-conductance calcium-activated K+ channels, the decreased sensitivity to ACh in indoxyl sulfate exposed vessel was still preserved. However, under inhibition of NO synthase (NOS) or inhibitions of NOS and COX, the difference of sensitivity to ACh between vehicle and indoxyl sulfate was eliminated. These findings indicated that acute exposure of indoxyl sulfate in the rat superior mesenteric artery specifically explicitly impaired NO signaling but not EDHF or vasodilator PGs.
37
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
A. Leone, S. Moncada, Patrick Vallance et al. · The Lancet · 1992 · 2.1K citations
Medicine, Nephrology, Pharmacology +11
Hiroaki Shimokawa, Hiroshi Yasutake, Koji Fujii et al. · Journal of Cardiovascular Pharmacology · 1996 · 672 citations
Medicine, Pharmacology, Physiology +15
Heike Wulff, Mark J. Miller, Wolfram Hänsel et al. · Proceedings of the National Academy of Sciences · 2000 · 606 citations · Full text
Dimethylarginine Dimethylaminohydrolase Regulates Nitric Oxide Synthesis
Hayan Dayoub, Vinod Achan, Shanthi Adimoolam et al. · Circulation · 2003 · 342 citations
Medicine, Cardiology, Pharmacology +14